← Leaderboards
Andrew Michael Fribley
University Of Michigan At Ann Arbor
$1,438,118
Attributed
$2,749,998
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2009–24$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,749,998 · 3
By mechanism
R01$1,749,173 · 1
R00$726,181 · 1
K99$274,644 · 1
Top collaborators
- Andrew P Ault2 shared
- Jeremy Kodanko2 shared
- Judy A Westrick2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Rebecca M. Cunningham$15,428,096
- Gregory James Dick$1,249,866
- Judy A Westrick$902,695
- George S Bullerjahn$988,959
- Robert D Brook$5,169,161
Others in their field
Top investigators on “Pharmacologic Substance”
- David Heimbrook · Leidos Biomedical Research, Inc.$127,683,054
- Myron S Cohen · Family Health International$104,232,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$104,068,526
- Garret A Fitzgerald · University Of Pennsylvania$73,814,804
- James Dennis Neaton · Northwestern University$65,107,995
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$53,206,876
Research focus
Pharmacologic SubstanceReportingPathway InteractionsCellsIn VitroInvestigationDoseLeadGrowthEnzymesApoptoticApoptosisChemotherapyDrug MetabolismAcademiaFundingDrug DevelopmentBreathingAffectDrug InteractionsCellular TargetingCaringCell DeathCell Line
Grant awards (7)
Synthesis and quantitation of microcystins and anabaenopeptins in the Great Lakes region to establish human exposure risks via ingestion and inhalation$139,586
R01 · FY2024 · ES
Synthesis and quantitation of microcystins and anabaenopeptins in the Great Lakes region to establish human exposure risks via ingestion and inhalation$1,609,587
R01 · FY2023 · ES
Genomic screening to identify novel stress-inducing chemotherapies for carcinoma$230,671
R00 · FY2013 · DE · contact PI
Genomic screening to identify novel stress-inducing chemotherapies for carcinoma$246,510
R00 · FY2012 · DE · contact PI
Genomic screening to identify novel stress-inducing chemotherapies for carcinoma$249,000
R00 · FY2011 · DE · contact PI
High Throughput Chemical Genomic screening to identify novel ER stress-inducing$137,322
K99 · FY2010 · DE · contact PI
High Throughput Chemical Genomic screening to identify novel ER stress-inducing$137,322
K99 · FY2009 · DE · contact PI